FcγRIIIA-158V and rheumatoid arthritis:: a confirmation study
FcγRIIIA-158V and rheumatoid arthritis:: a confirmation study
复制标题
DOI:
10.1093/rheumatology/keg169
复制
发表时间:
2003-04-01
期刊:
影响因子:
5.5
通讯作者:
Isaacs, JD
中科院分区:
文献类型:
--
作者:
Morgan, AW;Keyte, VH;Isaacs, JD
Objectives. To develop a robust assay for genotyping the FcgammaRIIIA-158V/F polymorphism and to confirm the putative association between the FcgammaRIIIA-158V allele and rheumatoid arthritis (RA).Methods. This allelic association study examined the FcgammaRIIIA-158V/F polymorphism for association with RA. A novel single-stranded conformational polymorphism assay was used to genotype 828 RA patients and 581 controls from the UK.Results. The FcgammaRIIIA-158V allele was associated with both RA (P=0.02) and nodules (P=0.04). Individuals homozygous for this higher affinity allele had a significantly increased risk of RA (OR 1.53, 95% CI 1.08-2.18) and the development of nodules (OR 2.20, 95% CI 1.20-4.01). There was no evidence of an interaction with the shared epitope.Conclusions. We have developed a novel assay to genotype the FcgammaRIIIA-158F/V polymorphism and confirmed that homozygosity for the FcgammaRIIIA-158V allele is associated with UK Caucasian RA, particularly in those individuals with nodules, suggesting FcgammaRIIIA may play a role in determining disease severity or in the development of nodules per se.